...BRCA2, we are identifying more and more women who have an 80% or more lifetime risk of developing breast cancer. Since t...
...BRCA2-mediated suppression of cell proliferation, indicating that MAGE-D1 is a downstream target of BRCA2 and that BRCA2...
...BRCA2 mutation carriers. Descriptive analyses were done followed by survival analyses and a Poisson regression analysis....
...BRCA2 genes. A joint analysis of the Polish and the German study population revealed a 54% increased risk for breast can...
...BRCA2, or TP53 mutation. We recruited participants from 22 centres in the UK, and offered the women annual screening wit...
...BRCA2 mutation testing is necessary for effective utilization of testing in the community. Education and counseling, whe...
Mutations in the known predisposing breast cancer genes BRCA1 and BRCA2 account for only a small proportion (<10%) of br...
...BRCA2 mutations. Medical records were reviewed to document the characteristics of each cancer and the treatments receive...
...BRCA2 loss of heterozygosity (LOH) is found in almost all BRCA1 and BRCA2 carcinomas, respectively. Furthermore, all typ...
...BRCA2, which are associated with a major risk of breast cancer during lifetime, has improved the assessment of the indiv...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
